leisure time -WSS

leisure time

author：Wikipedia 2025-09-05 13:30:34 - browse：4154

When is a billion-dollar deal a bad omen? Has Wall Street gone overboard on Ozempic? And how do you edit a chicken?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.

For more on what we cover, here’s the news on Mirati; here’s more on biotech venture capital; here’s the latest on Alnylam Pharmaceuticals; here’s more on NASH; here’s the story on xenotransplantation; here’s more on genome-edited chickens; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： How one medical school became remarkably diverse
Next article： Dramatically reducing cancer deaths requires the PASTEUR Act

focus

WSS

How I ended up pumping milk in a bathroom stall at JPM 2024

HHS names first

New Medicare drug pricing powers could soon be upended in court

Risky weight loss products often used by teens globally, per study

Verily hires former Apple Health leader as chief scientific officer

New Medicare drug pricing powers could soon be upended in court

explore

leisure time

focus

Drug repurposing or repositioning? The language matters

GSK to buy asthma

United colonoscopy coverage change 'may cost lives,' doctors say

The SUPPORT Act is critical to fighting the opioid crisis

Supreme Court strikes down use of affirmative action

New menopause drug shows promise in relief for hot flashes

How to save PrEP access — and even expand it

Generative AI mines health records to identify patients’ social needs

Medical records are filled with copy

What Mike Pence has said that could be used in a Donald Trump trial

hotspot

My superpower is killing ticks

TytoCare raises $49 million to build out AI

ProMED, early warning system on disease outbreaks, in peril

For BCIs, commercial hurdles may be bigger than scientific ones

Biotech reporter’s notebook: A sunnier mood at JPM 2024

TytoCare raises $49 million to build out AI

knowledge

leisure time

focus

explore